{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:54:06Z","timestamp":1791294846635,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["087622"],"award-info":[{"award-number":["087622"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000403","name":"Meningitis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jinf.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T12:17:31Z","timestamp":1496405851000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Frequent capsule switching in \u2018ultra-virulent\u2019 meningococci \u2013 Are we\u00a0ready for a serogroup B ST-11 complex\u00a0outbreak?"],"prefix":"10.1016","volume":"75","author":[{"given":"Jay","family":"Lucidarme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-2911","authenticated-orcid":false,"given":"Aiswarya","family":"Lekshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydel R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly B.","family":"Bratcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Jolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.J.","family":"Maiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jinf.2017.05.015_bib1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"issue":"45","key":"10.1016\/j.jinf.2017.05.015_bib2","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.45.30395","article-title":"An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015","volume":"21","author":"Lucidarme","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jinf.2017.05.015_bib3","series-title":"Evolution of meningococcal disease","article-title":"Evolution of meningococcal disease epidemiology in the US army","author":"Brundage","year":"1987"},{"issue":"Pt 7","key":"10.1016\/j.jinf.2017.05.015_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit","volume":"55","author":"Gray","year":"2006","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2017.05.015_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S0950268899004471","article-title":"Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world","volume":"125","author":"Jelfs","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"6144","key":"10.1016\/j.jinf.2017.05.015_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.341.6144.328","article-title":"Infectious diseases. Bacterial meningitis finds\u00a0new niche in gay communities","volume":"341","author":"Kupferschmidt","year":"2013","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.jinf.2017.05.015_bib7","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2016.02.014","article-title":"Global epidemiology of capsular group W meningococcal disease (1970\u20132015): multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex","volume":"34","author":"Mustapha","year":"2016","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.jinf.2017.05.015_bib8","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.vaccine.2013.07.083","article-title":"Effectiveness of meningococcal serogroup C vaccine programmes","volume":"31","author":"Borrow","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jinf.2017.05.015_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/archdischild-2015-308928","article-title":"Enter B and W: two new meningococcal vaccine programmes launched","volume":"101","author":"Ladhani","year":"2016","journal-title":"Arch Dis Child"},{"issue":"48","key":"10.1016\/j.jinf.2017.05.015_bib10","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.vaccine.2015.10.055","article-title":"The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations","volume":"33","author":"Safadi","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jinf.2017.05.015_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2017.05.015_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.micinf.2005.06.012","article-title":"Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37\/ST-11 clonal complex","volume":"8","author":"Lancellotti","year":"2006","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.jinf.2017.05.015_bib13","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future","volume":"9","author":"Holst","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.jinf.2017.05.015_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jinf.2017.05.015_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-3083.2012.02709.x","article-title":"An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt","volume":"76","author":"Norheim","year":"2012","journal-title":"Scand J Immunol"},{"issue":"7","key":"10.1016\/j.jinf.2017.05.015_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.vaccine.2012.12.031","article-title":"Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease","volume":"31","author":"Kaaijk","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jinf.2017.05.015_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14712598.2011.585965","article-title":"Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles","volume":"11","author":"Bai","year":"2011","journal-title":"Expert Opin Biol Ther"},{"issue":"45","key":"10.1016\/j.jinf.2017.05.015_bib18","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.jinf.2017.05.015_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2017.05.015_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30170-6","article-title":"Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007\u201308 and 2014\u201315: a qualitative and quantitative assessment","author":"Parikh","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2017.05.015_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/00325481.2016.1203238","article-title":"Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba(R))","volume":"128","author":"Gandhi","year":"2016","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.jinf.2017.05.015_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/MMBR.00056-12","article-title":"Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease","volume":"77","author":"McNeil","year":"2013","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jinf.2017.05.015_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinforma"},{"issue":"4","key":"10.1016\/j.jinf.2017.05.015_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W ST-11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2017.05.015_bib25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1186\/1471-2164-15-1138","article-title":"A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes","volume":"15","author":"Bratcher","year":"2014","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.jinf.2017.05.015_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/bioinformatics\/14.1.68","article-title":"SplitsTree: analyzing and visualizing evolutionary data","volume":"14","author":"Huson","year":"1998","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.jinf.2017.05.015_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1469-0691.2008.01955.x","article-title":"Hyperinvasive genotypes of Neisseria meningitidis in France","volume":"14","author":"Zarantonelli","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jinf.2017.05.015_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1099\/0022-1317-51-10-855","article-title":"Fatal outcome from meningococcal disease\u2013an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin","volume":"51","author":"Trotter","year":"2002","journal-title":"J Med Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2017.05.015_bib29","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/gbe\/evw122","article-title":"Genomic investigation reveals highly conserved, mosaic, recombination events associated with capsular switching among invasive Neisseria meningitidis serogroup W sequence type (ST)-11 strains","volume":"8","author":"Mustapha","year":"2016","journal-title":"Genome Biol Evol"},{"issue":"2","key":"10.1016\/j.jinf.2017.05.015_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3201\/eid2202.150369","article-title":"Effectiveness of meningococcal B vaccine against endemic hypervirulent Neisseria meningitidis W Strain, England","volume":"22","author":"Ladhani","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"Pt 2","key":"10.1016\/j.jinf.2017.05.015_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1099\/jmm.0.000006","article-title":"Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009\u20132013","volume":"64","author":"Tsang","year":"2015","journal-title":"J Med Microbiol"},{"issue":"6","key":"10.1016\/j.jinf.2017.05.015_bib32","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/CVI.00055-11","article-title":"Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein","volume":"18","author":"Lucidarme","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2017.05.015_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1514866","article-title":"Immunogenicity of a meningococcal B vaccine during a University outbreak","volume":"375","author":"Basta","year":"2016","journal-title":"N Engl J Med"},{"issue":"1688","key":"10.1016\/j.jinf.2017.05.015_bib34","first-page":"1635","article-title":"Long-term evolution of antigen repertoires among carried meningococci","volume":"277","author":"Buckee","year":"2010","journal-title":"Proc Biol Sci"},{"issue":"4","key":"10.1016\/j.jinf.2017.05.015_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","article-title":"The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"16","key":"10.1016\/j.jinf.2017.05.015_bib36","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"issue":"9960","key":"10.1016\/j.jinf.2017.05.015_bib37","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(14)60842-4","article-title":"Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial","volume":"384","author":"Read","year":"2014","journal-title":"Lancet"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317301639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445317301639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:09Z","timestamp":1759008309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445317301639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0163445317301639"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2017.05.015","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequent capsule switching in \u2018ultra-virulent\u2019 meningococci \u2013 Are we\u00a0ready for a serogroup B ST-11 complex\u00a0outbreak?","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}